109 related articles for article (PubMed ID: 20067437)
1. Development and evaluation of occlusive systems employing polyvinyl alcohol for transdermal delivery of sumatriptan succinate.
Balaguer-Fernández C; Padula C; Femenía-Font A; Merino V; Santi P; López-Castellano A
Drug Deliv; 2010 Feb; 17(2):83-91. PubMed ID: 20067437
[TBL] [Abstract][Full Text] [Related]
2. Sumatriptan succinate transdermal delivery systems for the treatment of migraine.
Balaguer-Fernández C; Femenía-Font A; Del Rio-Sancho S; Merino V; López-Castellano A
J Pharm Sci; 2008 Jun; 97(6):2102-9. PubMed ID: 17854062
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo evaluation of the transdermal iontophoretic delivery of sumatriptan succinate.
Patel SR; Zhong H; Sharma A; Kalia YN
Eur J Pharm Biopharm; 2007 May; 66(2):296-301. PubMed ID: 17182233
[TBL] [Abstract][Full Text] [Related]
4. Nasal drug delivery of sumatriptan succinate.
Chavanpatil MD; Vavia PR
Pharmazie; 2005 May; 60(5):347-9. PubMed ID: 15918583
[TBL] [Abstract][Full Text] [Related]
5. Development and in vitro evaluation of furosemide transdermal formulations using experimental design techniques.
Agyralides GG; Dallas PP; Rekkas DM
Int J Pharm; 2004 Aug; 281(1-2):35-43. PubMed ID: 15288341
[TBL] [Abstract][Full Text] [Related]
6. Zelrix: a novel transdermal formulation of sumatriptan.
Pierce M; Marbury T; O'Neill C; Siegel S; Du W; Sebree T
Headache; 2009 Jun; 49(6):817-25. PubMed ID: 19438727
[TBL] [Abstract][Full Text] [Related]
7. Combination strategies for enhancing transdermal absorption of sumatriptan through skin.
Femenía-Font A; Balaguer-Fernández C; Merino V; López-Castellano A
Int J Pharm; 2006 Oct; 323(1-2):125-30. PubMed ID: 16809010
[TBL] [Abstract][Full Text] [Related]
8. Design and in vivo evaluation of an indapamide transdermal patch.
Ren C; Fang L; Ling L; Wang Q; Liu S; Zhao L; He Z
Int J Pharm; 2009 Mar; 370(1-2):129-35. PubMed ID: 19114099
[TBL] [Abstract][Full Text] [Related]
9. Bioadhesive monolayer film for the in vitro transdermal delivery of sumatriptan.
Femenía-Font A; Padula C; Marra F; Balaguer-Fernández C; Merino V; López-Castellano A; Nicoli S; Santi P
J Pharm Sci; 2006 Jul; 95(7):1561-9. PubMed ID: 16721755
[TBL] [Abstract][Full Text] [Related]
10. New transdermal bioadhesive film containing oxybutynin: In vitro permeation across rabbit ear skin.
Nicoli S; Penna E; Padula C; Colombo P; Santi P
Int J Pharm; 2006 Nov; 325(1-2):2-7. PubMed ID: 16860952
[TBL] [Abstract][Full Text] [Related]
11. Effect of chemical enhancers on the in vitro percutaneous absorption of sumatriptan succinate.
Femenía-Font A; Balaguer-Fernández C; Merino V; Rodilla V; López-Castellano A
Eur J Pharm Biopharm; 2005 Sep; 61(1-2):50-5. PubMed ID: 15925502
[TBL] [Abstract][Full Text] [Related]
12. Rapid absorption of sumatriptan powder and effects on glyceryl trinitrate model of headache following intranasal delivery using a novel bi-directional device.
Luthringer R; Djupesland PG; Sheldrake CD; Flint A; Boeijinga P; Danjou P; Demazières A; Hewson G
J Pharm Pharmacol; 2009 Sep; 61(9):1219-28. PubMed ID: 19703372
[TBL] [Abstract][Full Text] [Related]
13. A unique iontophoretic patch for optimal transdermal delivery of sumatriptan.
Siegel SJ; O'Neill C; Dubé LM; Kaldeway P; Morris R; Jackson D; Sebree T
Pharm Res; 2007 Oct; 24(10):1919-26. PubMed ID: 17577644
[TBL] [Abstract][Full Text] [Related]
14. Improvement of transdermal delivery of sumatriptan succinate using a novel self-dissolving microneedle array fabricated from sodium hyaluronate in rats.
Wu D; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
Biol Pharm Bull; 2015; 38(3):365-73. PubMed ID: 25757917
[TBL] [Abstract][Full Text] [Related]
15. A drug-in-adhesive transdermal patch for S-amlodipine free base: in vitro and in vivo characterization.
Sun Y; Fang L; Zhu M; Li W; Meng P; Li L; He Z
Int J Pharm; 2009 Dec; 382(1-2):165-71. PubMed ID: 19716871
[TBL] [Abstract][Full Text] [Related]
16. Elastic vesicles of sumatriptan succinate for transdermal administration: characterization and in vitro permeation studies.
Balaguer-Fernández C; Femenía-Font A; Merino V; Córdoba-Díaz D; Elorza-Barroeta MA; López-Castellano A; Córdoba-Díaz M
J Liposome Res; 2011 Mar; 21(1):55-9. PubMed ID: 20429812
[TBL] [Abstract][Full Text] [Related]
17. Sumatriptan iontophoretic transdermal system: history, study results, and use in clinical practice.
Pierce M; O'Neill C; Felker E; Sebree T
Headache; 2013 Sep; 53 Suppl 2():34-42. PubMed ID: 24024601
[TBL] [Abstract][Full Text] [Related]
18. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
[TBL] [Abstract][Full Text] [Related]
19. Formulation and evaluation of nasal mucoadhesive microspheres of sumatriptan succinate.
Jain SA; Chauk DS; Mahajan HS; Tekade AR; Gattani SG
J Microencapsul; 2009 Dec; 26(8):711-21. PubMed ID: 19888880
[TBL] [Abstract][Full Text] [Related]
20. Damar Batu as a novel matrix former for the transdermal drug delivery: in vitro evaluation.
Mundada AS; Avari JG
Drug Dev Ind Pharm; 2009 Sep; 35(9):1147-54. PubMed ID: 19555240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
